<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01729364</url>
  </required_header>
  <id_info>
    <org_study_id>vätskestudien</org_study_id>
    <nct_id>NCT01729364</nct_id>
  </id_info>
  <brief_title>Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function</brief_title>
  <official_title>Colloid vs Crystalloid Infusion Postoperative in CABG Patients Regarding Renal Hemodynamics and Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the effects of crystalloid versus colloid fluid resuscitation in CABG patients
      postoperatively regarding renal blood flow, glomerular filtration rate and renal oxygen
      demand.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to blood loss and SIRS postoperative hypovolemia is a usual feature after CABG surgery.
      Substantial controversy persists regarding the best choice of fluid to be used for
      resuscitation in this setting regarding renal function and oxygen supply-demand matching. In
      our study we aim to investigate differences in functional renal parameters by dividing
      patients postoperatively in two groups, substituted either with crystalloid fluid,
      Ringer-Acetat, 20 ml/kg or colloid, HES 6% (130/0,4) 10 ml/kg under 20 minutes. Central and
      renal hemodynamics will be measured before (baseline) and after fluid administration by blood
      sampling and thermodilution in both pulmonary artery catheter and renal vein catheter.
      Measurement endpoints will mainly consist of central hemodynamics, renal blood flow, GFR and
      renal oxygen extraction rate which we aim to compare between groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline and differences inbetween groups in glomerular filtration rate, measured at different timepoints</measure>
    <time_frame>125min after baseline-measures</time_frame>
    <description>GFR measured by thermodilution and blood- and urine sampling baseline1 (0min), baseline2 (+30min), timepoint1 (+65min), tp2 (+85min), tp3 (+105min), tp4 (+125min)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Renal Impairment</condition>
  <arm_group>
    <arm_group_label>crystalloid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>crystalloid fluid administration, Ringer-acetat 20ml/kg under 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>colloid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>colloidal fluids administration, HES 6% (130/0,4) 7ml/kg under 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>crystalloid</intervention_name>
    <arm_group_label>crystalloid</arm_group_label>
    <other_name>Ringer Lactate</other_name>
    <other_name>NaCl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>colloid</intervention_name>
    <arm_group_label>colloid</arm_group_label>
    <other_name>Voluven</other_name>
    <other_name>Venofundin</other_name>
    <other_name>Tetraspan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective fast track CABG patients, postoperative

        Exclusion Criteria:

          -  hemodynamic instability

          -  preoperative renal impairment

          -  major postoperative bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jenny Skytte Larsson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sven-Erik Ricksten, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital/Thoracic Intensive Care</name>
      <address>
        <city>Göteborg</city>
        <state>Västra Götaland</state>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2012</study_first_submitted>
  <study_first_submitted_qc>November 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2012</study_first_posted>
  <last_update_submitted>May 20, 2015</last_update_submitted>
  <last_update_submitted_qc>May 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Jenny Skytte Larsson</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>elective CABG</keyword>
  <keyword>renal impairment</keyword>
  <keyword>GFR</keyword>
  <keyword>renal blood flow</keyword>
  <keyword>colloid</keyword>
  <keyword>crystalloid</keyword>
  <keyword>thermodilution technique</keyword>
  <keyword>oxygen supply demand</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

